Global Cell Imaging Systems Market was Valued at US$ XX Mn in 2018

01/feb/2019 10:32:48 Rajesh Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Cell Imaging Systems Market was Valued at US$ XX Mn in 2018, Due to Increasing Prevalence of Chronic Diseases such as Cancer and Growing Geriatric Population

Analyst Speak:


The Global Cell Imaging Systems Market was valued around US$ XX Mn by 2018 and growing at a significant CAGR over seven years forecast period 2019-2025” owing to increasing prevalence of chronic diseases and growing geriatric population and availability of advanced technology like high field strength.


Precision Business Insights (PBI) in its report titled “Global Cell Imaging Systems Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.


The global cell imaging systems market was valued at US$ XX Mn in 2018 and growing at a significant CAGR over the forecast period owing to increasing demand for the non-invasive and minimally invasive diagnostic procedures and increasing geriatric population and chronic diseases are major driving factors of cell imaging systems market over the forecast period. Moreover, rising awareness among the people regarding their health in developing economic countries and wide range of applications offered by the cell line systems fuels the growth of the market. However, lack of skilled professionals and high cost for the diagnosis hampers the growth of the market


A sample of this report is available upon request @


Global cell imaging systems market segmented on the basis of technology, component type, application, and end user.


Software Cell Imaging Systems accounted for higher revenue share


Based on Components, global cell imaging systems market segmented into equipment, consumables, and software. Software cell imaging systems market registered higher growth rate in 2018 and projected to dominate over the forecast period owing to adoption of physicians and professionals to advanced technologies and approvals for the novel technologies in healthcare IT along with increasing incidence rate of chronic diseases such as cancer boosts the growth of the market. In addition, companies heavily investing in development and receiving approval for novel technologies and also acquisitions and mergers among the companies expected to fuel the growth of the market over forecast period.

North America leads the global Cell Imaging Systems market


PBI’s global cell imaging systems market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America holds larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 due to higher adoption to advanced technology and availability of favorable fee reimbursement policies drives the growth of the market over forecast years. Europe expected to witness the highest growth rate during the forecast period due to increasing approvals for the usage of cell imaging systems from the governing bodies and rising prevalence of chronic diseases.


To view TOC of this report is available upon request @


Acquisitions & Mergers and strategic alliances and Launch of New Products are the key strategies adopted by the market players


Global cell imaging systems market further reveals that the key player’s increasingly adopting strategies such as acquisitions & mergers and strategic alliance and launch of novel and technology based products to improve market revenue share and strengthening their presence across the region.


Key player’s profiles in the report are Leica Microsystems (Germany), Thermo Fisher Scientific, Inc. (U.S.)., Carl Zeiss AG (Germany), Molecular Devices, LCC (U.S.), Nikon Corporation (Japan), PerkinElmer, Inc. (U.S.), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), Sigma-Aldrich Corporation (U.S.), and Olympus Corporation (Japan)


Need more information about this report @


Detailed Segmentation


By Technology

  • Multiphoton Excitation Microscopy
  • Fluorescence In Situ Hybridization
  • High-Content Analysis
  • Fluorescence Resonance Energy Transfer
  • Ratio metric Imaging
  • Fluorescence Resonance After Photo bleaching
  • Total Internal Reflection Fluorescence Microscopy
  • Others

By Components

  • Equipment
  • Consumables
  • Software  

By Application

  • Drug Discovery
  • Stem Cells
  • Cell Biology
  • Developmental Biology

By End User

  • Research Institutes
  • Diagnostic Centers
  • Hospitals



  • North America
  • S
  • Canada
  • Europe
  • Germany
  • France
  • K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Rest of Asia-Pacific
  • Rest of World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Others


Get access to full summary @


About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Contact Person: Rajesh Babu

Role: Marketing Lead


Toll Free (US):+1-866-598-1553

Website @

blog comments powered by Disqus è un servizio offerto da Factotum Srl